Mirae Asset Global ETFs Holdings’s Tyra Biosciences TYRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Buy	21,364 +6,738	+46%	+$223K	﹤0.01%	1837
2026 Q1	$551K	Buy	14,626 +1,718	+13%	+$55.6K	﹤0.01%	1843
2025 Q4	$339K	Buy	12,908 +1,591	+14%	+$29.2K	﹤0.01%	2092
2025 Q3	$158K	Sell	11,317 -1,865	-14%	-$21.3K	﹤0.01%	2447
2025 Q2	$126K	Buy	13,182 +1,668	+14%	+$15.8K	﹤0.01%	2490
2025 Q1	$107K	Sell	11,514 -127	-1%	-$1.64K	﹤0.01%	2603
2024 Q4	$162K	Buy	11,641 +532	+5%	+$9.65K	﹤0.01%	2485
2024 Q3	$261K	Buy	11,109 +4,601	+71%	+$96.6K	﹤0.01%	2234
2024 Q2	$104K	Buy	+6,508	New	+$112K	﹤0.01%	2543

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TYRA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tyra Biosciences (TYRA) stake by 46% in Q2 2026, buying an estimated $223K and bringing the position to 21,364 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Mirae Asset Global ETFs Holdings first reported a position in TYRA in Q2 2024 and has held it in 9 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 21,364 shares of Tyra Biosciences worth $683K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 6,738 Tyra Biosciences shares in Q2 2026, an estimated $223K.
Tyra Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1837 holding.
Mirae Asset Global ETFs Holdings first reported a position in Tyra Biosciences in Q2 2024 and has held it in 9 quarters since.
168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.